NextEye넥스트아이

NextEye's revenue has grown fast but losses are deep, and the share price has fallen sharply over the past year.

NextEye is a small Korean machine vision and inspection equipment maker that also runs a cosmetics business, which the profile says accounts for most of revenue. Trailing twelve-month revenue to H1 2026 was about ₩217B, but operating losses were about ₩32B and net losses about ₩36B, and the company has a negative return on equity. At ₩1,980 the market value is about ₩19B, and the stock is down 42.1% over one year.

What stands out

• Revenue rose from ₩17.7B in 2023 to ₩120.1B in 2025, but operating margin was -29.6% in 2025 and losses widened.
• Trailing free cash flow is slightly negative at about -₩0.3B, while cash of ₩19.4B exceeds borrowings of ₩3.4B.
• Liabilities are 97.8% of equity, and the book value multiple is 0.4, which the data does not explain further.
• Filings include a rights offering decision dated 2026-06-30 and a securities issuance results notice from July 2026; the data does not give the terms or size of the offering.
• A news report from 2026-10-14 says NextEye teamed up with China's national robot team on AI inspection robots for defense and battery markets; the data does not show any revenue impact.

What to watch

• The H1 2026 half-year report was amended on 2026-09-30, so check the filed figures and any further changes.
• Details and dilution effect of the 2026 rights offering, which the data does not include.
• Whether the cosmetics business and China exposure keep driving revenue while operating losses persist.